10 likes | 155 Views
This article discusses the importance of the mitotic index in evaluating patient samples, as highlighted by Edina K-P. et al. in their 2011 review. They argue that prematurely targeting mitosis in clinical settings may not be appropriate. The review emphasizes the need for caution and further research before implementing mitotic targeting strategies in oncology. The findings suggest that while the mitotic index can provide valuable information, a nuanced approach is essential for effective treatment planning.
E N D
Table 1 Mitotic index in patient samples Edina, K-P. et al.(2011) (Not) too early to say, “no targeting of mitosis!” Nat. Rev. Clin. Oncol.doi:10.1038/nrclinonc.2010.228-c2